PHASE III TRIAL SHOWS VERACYTE’S DECIPHER PROSTATE TEST CAN PREDICT BENEFIT FROM ADDING ABIRATERONE TO TREATMENT IN VERY HIGH-RISK PROSTATE CANCER

Reuters · 3d ago

Please log in to view news